(CPAY) Corpay - Overview
Stock: Fuel Cards, Virtual Cards, Lodging Payments, Fleet Maintenance, Gift Cards
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 44.0% |
| Relative Tail Risk | -8.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.14 |
| Alpha | -29.28 |
| Character TTM | |
|---|---|
| Beta | 1.413 |
| Beta Downside | 1.512 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.54% |
| CAGR/Max DD | 0.57 |
Description: CPAY Corpay December 19, 2025
Corpay Inc. (NYSE: CPAY) is a diversified payments firm that enables businesses and consumers to manage vehicle-related costs, lodging expenses, and broader corporate payments across the United States, Brazil, the United Kingdom, and other international markets.
The company’s portfolio includes fuel, toll, parking, compliance, and fleet-maintenance solutions; prepaid food and transportation vouchers; corporate accounts-payable automation, virtual-card issuance, cross-border payment services, and travel-and-entertainment (T&E) card products; as well as lodging-payment platforms for overnight business travelers, airline crew, cruise passengers, and disaster-displaced policyholders. It also offers gift and payroll cards, serving business, merchant, consumer, and payment-network customers.
Originally founded in 1986 as Fleetcor Technologies, the firm rebranded to Corpay Inc. in March 2024 and remains headquartered in Atlanta, Georgia.
Key operating metrics (FY 2023) show total revenue of approximately $1.2 billion, with a 15% year-over-year increase in gross transaction volume driven by expanding virtual-card adoption and cross-border payment demand. The corporate payments sector is benefitting from a post-COVID rebound in business travel spend and accelerated digitization of AP processes, which together underpin a projected 9% CAGR for the next three years.
For a deeper dive into CPAY’s valuation metrics and peer comparison, check out the detailed analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 1.07b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -8.60 > 1.0 |
| NWC/Revenue: -7.36% < 20% (prev -0.81%; Δ -6.56% < -1%) |
| CFO/TA 0.05 > 3% & CFO 1.34b > Net Income 1.07b |
| Net Debt (5.68b) to EBITDA (2.34b): 2.43 < 3 |
| Current Ratio: 0.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (70.1m) vs 12m ago -1.88% < -2% |
| Gross Margin: 82.28% > 18% (prev 0.78%; Δ 8150 % > 0.5%) |
| Asset Turnover: 20.41% > 50% (prev 22.13%; Δ -1.72% > 0%) |
| Interest Coverage Ratio: 4.81 > 6 (EBITDA TTM 2.34b / Interest Expense TTM 403.8m) |
Altman Z'' 2.19
| A: -0.01 (Total Current Assets 13.97b - Total Current Liabilities 14.31b) / Total Assets 26.42b |
| B: 0.39 (Retained Earnings 10.26b / Total Assets 26.42b) |
| C: 0.09 (EBIT TTM 1.94b / Avg Total Assets 22.19b) |
| D: 0.39 (Book Value of Equity 8.87b / Total Liabilities 22.54b) |
| Altman-Z'' Score: 2.19 = BBB |
Beneish M -3.11
| DSRI: 0.91 (Receivables 2.16b/2.09b, Revenue 4.53b/3.97b) |
| GMI: 0.95 (GM 82.28% / 78.13%) |
| AQI: 0.91 (AQ_t 0.45 / AQ_t-1 0.50) |
| SGI: 1.14 (Revenue 4.53b / 3.97b) |
| TATA: -0.01 (NI 1.07b - CFO 1.34b) / TA 26.42b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of CPAY shares?
Over the past week, the price has changed by +12.57%, over one month by +11.51%, over three months by +27.41% and over the past year by -9.08%.
Is CPAY a buy, sell or hold?
- StrongBuy: 6
- Buy: 6
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CPAY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 373.6 | 5.5% |
| Analysts Target Price | 373.6 | 5.5% |
| ValueRay Target Price | 385.6 | 8.9% |
CPAY Fundamental Data Overview February 07, 2026
P/E Forward = 12.1803
P/S = 5.2239
P/B = 5.4088
P/EG = 0.8705
Revenue TTM = 4.53b USD
EBIT TTM = 1.94b USD
EBITDA TTM = 2.34b USD
Long Term Debt = 5.82b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.52b USD (from shortTermDebt, last quarter)
Debt = 8.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.68b USD (from netDebt column, last quarter)
Enterprise Value = 29.34b USD (23.66b + Debt 8.18b - CCE 2.50b)
Interest Coverage Ratio = 4.81 (Ebit TTM 1.94b / Interest Expense TTM 403.8m)
EV/FCF = 25.66x (Enterprise Value 29.34b / FCF TTM 1.14b)
FCF Yield = 3.90% (FCF TTM 1.14b / Enterprise Value 29.34b)
FCF Margin = 25.25% (FCF TTM 1.14b / Revenue TTM 4.53b)
Net Margin = 23.62% (Net Income TTM 1.07b / Revenue TTM 4.53b)
Gross Margin = 82.28% ((Revenue TTM 4.53b - Cost of Revenue TTM 802.3m) / Revenue TTM)
Gross Margin QoQ = none% (prev 70.84%)
Tobins Q-Ratio = 1.11 (Enterprise Value 29.34b / Total Assets 26.42b)
Interest Expense / Debt = 1.38% (Interest Expense 113.0m / Debt 8.18b)
Taxrate = 33.49% (133.8m / 399.4m)
NOPAT = 1.29b (EBIT 1.94b * (1 - 33.49%))
Current Ratio = 0.98 (Total Current Assets 13.97b / Total Current Liabilities 14.31b)
Debt / Equity = 2.11 (Debt 8.18b / totalStockholderEquity, last quarter 3.88b)
Debt / EBITDA = 2.43 (Net Debt 5.68b / EBITDA 2.34b)
Debt / FCF = 4.97 (Net Debt 5.68b / FCF TTM 1.14b)
Total Stockholder Equity = 3.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.82% (Net Income 1.07b / Total Assets 26.42b)
RoE = 27.89% (Net Income TTM 1.07b / Total Stockholder Equity 3.84b)
RoCE = 20.13% (EBIT 1.94b / Capital Employed (Equity 3.84b + L.T.Debt 5.82b))
RoIC = 10.82% (NOPAT 1.29b / Invested Capital 11.96b)
WACC = 8.50% (E(23.66b)/V(31.83b) * Re(11.12%) + D(8.18b)/V(31.83b) * Rd(1.38%) * (1-Tc(0.33)))
Discount Rate = 11.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.31%
[DCF Debug] Terminal Value 79.65% ; FCFF base≈1.61b ; Y1≈1.99b ; Y5≈3.39b
Fair Price DCF = 662.8 (EV 52.05b - Net Debt 5.68b = Equity 46.37b / Shares 70.0m; r=8.50% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 48.49 | EPS CAGR: 14.38% | SUE: 0.32 | # QB: 0
Revenue Correlation: 94.42 | Revenue CAGR: 13.00% | SUE: 1.00 | # QB: 2
EPS next Quarter (2026-03-31): EPS=5.46 | Chg30d=-0.006 | Revisions Net=-4 | Analysts=12
EPS current Year (2026-12-31): EPS=25.92 | Chg30d=+1.087 | Revisions Net=-5 | Growth EPS=+21.2% | Growth Revenue=+16.5%
EPS next Year (2027-12-31): EPS=29.42 | Chg30d=+0.686 | Revisions Net=-4 | Growth EPS=+13.5% | Growth Revenue=+9.9%